glp-1 employer healthcare costs drugs could lead to cost savings for workers and their employers by reducing employee sick leave, a new economic study finds Employer healthcare spending in 2025:

Is daily dosing with Saxenda or weekly dosing with Ozempic easier

While it's essential to recognize that the FDA does not endorse off-label use, the demand for Ozempics weight loss magic couldn't be ignored, leading to practitioners across the country taking the obesity fight into their own handsor prescription pads

In Washington, Kaisers individual and family plans list Mounjaro as a Tier 4 drug

Check out more of NPR's coverage about GLP-1s

If you're unsure or want to switch safely from one medication to the other, we can help

Short half-life, pleiotropy, and behavioral or cardiovascular effects were historically interpreted as disqualifying features